CRIS Cancer and Gustave Roussy are partnering to support the development of practice-changing or practice-informing clinical trials in France and Spain.
The aim of the GR-CRIS Real-Life Trials in Oncology Programme is to provide competitive funding conditions to clinical researchers to develop «Real-life Trials / Pragmatic Trials» in France and Spain, understanding “Real-life Trials / Pragmatic Trial” as a type of clinical study designed to evaluate new treatment approaches under real world conditions that can be implemented in routine clinical practice across diverse healthcare settings.
Call for Applications 2025 – GR-CRIS Real-Life Trials in Oncology Programme
In 2025, Gustave Roussy and CRIS Cancer run the fourth GR-CRIS Real-Life Trials in Oncology Programme call.
The maximum grant awarded will be €1,500,000, which will be spread over the awarded proposals, for three years, with annual instalments of up to €500,000 a year.
The 2025 call for applications opens on 1 April 2025 and closes on 16 June 2025 at 23:59 (Central European Time – CET).
All applications must be submitted by filling the form during the application submission period for the 2025 call.
Deadline: June 16, 2025
Español
English